Clover Health looks very different from the CLOV investors remember from the meme-stock days.
Revenue has jumped, Medicare Advantage membership is growing fast, and the company has moved from a quarterly loss to a real GAAP profit.
Now Clover has also received a 5-Star Medicare rating, which could improve future economics and help with member growth.
But there’s another part of the story: Counterpart Health.
In this video, I look at what’s actually driving Clover’s turnaround, why the 5-Star rating matters, the court case behind part of that rating, and whether Counterpart can eventually become a meaningful healthcare technology business.
The insurance turnaround looks real.
The bigger question is whether Clover can actually build a second business around its technology.
